Testosterone Levels in Women: Normal Ranges by Age and What They Mean

Medical Summary

In clinical practice, we frequently evaluate female hormone profiles to understand symptoms related to energy, libido, and metabolic health. While predominantly recognised as a male hormone, testosterone is an essential androgen in women, produced by the ovaries and adrenal glands. Normal testosterone levels in women typically range from 0.5 to 2.4 nmol/L, though these reference values fluctuate significantly across different life stages, including the menstrual cycle, perimenopause, and postmenopause. Accurate assessment requires sensitive laboratory techniques, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS), because female concentrations are approximately ten to twenty times lower than those found in men. Deviations from these established ranges can indicate underlying endocrine conditions; elevated levels are often associated with polycystic ovary syndrome (PCOS)^[4], whereas diminished concentrations may contribute to reduced sexual desire and fatigue, particularly following menopause.

Why Women Produce Testosterone

Testosterone serves several critical physiological functions in the female body. It is synthesised primarily in the ovaries and the adrenal glands, with peripheral tissues converting precursor hormones into active androgens. This hormone is vital for maintaining bone density^[1], supporting muscle mass, and regulating mood and cognitive function. Furthermore, testosterone acts as a crucial precursor for oestrogen production.

Patients often ask us about the role of androgens in female health. Beyond its structural benefits, testosterone is a key driver of sexual desire and arousal in women. The delicate balance of this hormone, alongside oestrogen and progesterone, ensures optimal reproductive and metabolic function. When this equilibrium is disrupted, women may experience a range of physical and emotional symptoms that prompt clinical investigation.

The production of testosterone in women is a complex process that involves multiple organs and feedback loops. The hypothalamus and pituitary gland in the brain regulate the release of luteinising hormone (LH), which in turn stimulates the ovaries to produce androgens. The adrenal glands also contribute significantly to the circulating pool of androgens, producing dehydroepiandrosterone (DHEA) and androstenedione, which are then converted into testosterone in peripheral tissues such as fat and muscle.

This intricate system ensures that women have a steady supply of androgens to support their physiological needs. However, it also means that disruptions at any point in this pathway—whether due to ovarian dysfunction, adrenal issues, or alterations in peripheral conversion—can lead to abnormal testosterone levels. Understanding these underlying mechanisms is essential for accurately diagnosing and managing hormonal imbalances in women.

Normal Testosterone Levels in Women by Age

Understanding what constitutes a normal testosterone level in a woman requires context, as concentrations naturally evolve throughout a woman’s lifespan. During the reproductive years, levels peak and exhibit cyclical variations. As women transition through perimenopause and into postmenopause, ovarian production declines, leading to a gradual reduction in circulating androgens^[2].

The table below outlines the typical reference ranges for total testosterone in women, measured in nanomoles per litre (nmol/L). It is crucial to remember that specific laboratory reference ranges may vary slightly depending on the assay used.

Life Stage	Typical Age Range	Total Testosterone Range (nmol/L)
Reproductive Years	18–40 years	0.5 – 2.4 nmol/L
Perimenopause	40–50 years	0.4 – 2.0 nmol/L
Postmenopause	50+ years	0.3 – 1.7 nmol/L

During the reproductive years, typically spanning from the late teens to the late thirties, women experience their highest levels of testosterone. This period is characterised by regular menstrual cycles and optimal fertility. The relatively higher androgen concentrations during this time support bone health, muscle mass, and sexual function. However, even within this life stage, individual variations are common, and what is considered normal for one woman may differ slightly for another.

As women enter perimenopause, usually in their forties, hormonal fluctuations become more pronounced. Ovarian function begins to decline, leading to irregular menstrual cycles and a gradual decrease in both oestrogen and testosterone production. This transitional phase can last for several years and is often accompanied by symptoms such as hot flushes, mood swings, and changes in libido. The decline in testosterone during perimenopause can contribute to feelings of fatigue and a reduction in sexual desire.

Postmenopause, defined as the period following 12 consecutive months without a menstrual period, marks a significant shift in a woman’s hormonal landscape. Ovarian production of oestrogen and testosterone drops dramatically, although the adrenal glands continue to produce some androgens. The lower testosterone levels characteristic of postmenopause can exacerbate symptoms such as decreased bone density, loss of muscle mass, and persistent low libido. Understanding these age-related changes is essential for interpreting blood test results and determining appropriate management strategies.

Understanding Free Androgen Index (FAI) and SHBG

Total testosterone measurements only provide part of the clinical picture. The majority of testosterone in the bloodstream is bound to proteins, primarily sex hormone-binding globulin (SHBG) and albumin. Only a small fraction, known as free testosterone, is biologically active and available to bind to androgen receptors in tissues.

To accurately assess a woman’s androgen status, clinicians often calculate the Free Androgen Index (FAI). This is derived by dividing the total testosterone concentration by the SHBG level and multiplying by 100. A normal FAI in women is generally considered to be less than 4 or 5^[3], depending on the laboratory. Elevated SHBG levels, which can be influenced by oral contraceptives or pregnancy, will lower the FAI, whereas conditions like insulin resistance can decrease SHBG, thereby increasing the proportion of active, free testosterone.

SHBG plays a crucial role in regulating the bioavailability of sex hormones. It acts as a transport protein, carrying testosterone and oestrogen through the bloodstream and controlling their access to target tissues. The production of SHBG in the liver is influenced by various factors, including hormonal status, metabolic health, and certain medications. For example, oestrogen increases SHBG production, which is why women taking oral contraceptives often have elevated SHBG levels and correspondingly lower free testosterone.

Conversely, insulin resistance and obesity are associated with decreased SHBG production. This reduction in SHBG leads to an increase in the proportion of free, biologically active testosterone, even if total testosterone levels remain within the normal range. This mechanism is particularly relevant in conditions like polycystic ovary syndrome (PCOS), where insulin resistance is a common underlying factor contributing to hyperandrogenism.

How Female Levels Compare to Male Ranges

The disparity between male and female androgen concentrations is substantial. While average testosterone levels in females sit between 0.5 and 2.4 nmol/L, healthy adult men typically exhibit concentrations ranging from 15 to 30 nmol/L. This means that female levels are roughly ten to twenty times lower than normal male testosterone levels.

Because women operate on such a narrow and low reference range, precise measurement is paramount. Standard immunoassays, which are often sufficient for male testing, can lack the necessary sensitivity and specificity to accurately quantify the minute amounts of testosterone present in female serum.

This significant difference in testosterone concentrations between the sexes is responsible for many of the physical and physiological distinctions between men and women. In men, higher testosterone levels drive the development of male secondary sexual characteristics, such as increased muscle mass, facial and body hair growth, and a deeper voice. In women, the lower levels of testosterone are sufficient to support essential functions like bone health and libido without inducing these masculinising effects.

However, the narrow reference range for women means that even relatively small absolute changes in testosterone concentrations can have a profound impact on their health and well-being. An increase of just a few nanomoles per litre, which might be clinically insignificant in a man, can lead to noticeable symptoms of hyperandrogenism in a woman, such as hirsutism and acne. Conversely, a slight decrease can contribute to symptoms of androgen deficiency, such as fatigue and low libido.

Testing Methods: Why LC-MS/MS is Preferred

When investigating a woman’s testosterone levels, the choice of laboratory technique is critical. Due to the low concentrations involved, traditional testing methods can sometimes yield inaccurate or variable results. For this reason, liquid chromatography-tandem mass spectrometry (LC-MS/MS) is considered the gold standard for measuring female androgens.

LC-MS/MS offers superior analytical sensitivity and specificity, allowing for the precise quantification of testosterone even at the lower end of the female reference range. If you are arranging a testosterone blood test, ensuring that the laboratory utilises mass spectrometry will provide the most reliable data for clinical decision-making.

Standard immunoassays, which rely on antibodies to detect and measure hormones, are widely used in clinical laboratories due to their speed and cost-effectiveness. However, these assays can suffer from cross-reactivity, where the antibodies inadvertently bind to other structurally similar steroid hormones, leading to falsely elevated testosterone readings. This issue is particularly problematic in women, where the true testosterone concentration is very low, and the presence of interfering substances can significantly skew the results.

In contrast, LC-MS/MS physically separates the molecules in a sample based on their chemical properties and then measures their mass-to-charge ratio. This highly specific approach virtually eliminates the risk of cross-reactivity, ensuring that only testosterone is quantified. The enhanced sensitivity of LC-MS/MS also allows for accurate measurement at concentrations well below the detection limits of many standard immunoassays.

Fluctuations During the Menstrual Cycle

A woman’s testosterone level is not static; it fluctuates in tandem with the menstrual cycle. Concentrations typically begin to rise during the follicular phase, peaking mid-cycle around the time of ovulation. This mid-cycle surge in androgens is thought to play a role in enhancing libido during the fertile window.

Following ovulation, during the luteal phase, testosterone levels gradually decline. When interpreting blood test results, clinicians must consider the specific day of the menstrual cycle on which the sample was drawn, as a reading taken during ovulation will naturally be higher than one taken during menstruation.

The menstrual cycle is a complex interplay of hormones, primarily driven by the hypothalamus, pituitary gland, and ovaries. During the early follicular phase, as a new cohort of ovarian follicles begins to develop, testosterone levels are relatively low. As the dominant follicle matures and approaches ovulation, it produces increasing amounts of oestrogen and androgens, leading to the characteristic mid-cycle peak in testosterone.

This transient increase in testosterone around ovulation is believed to have evolutionary significance, potentially boosting sexual desire and arousal at the time of peak fertility. Some women report a noticeable increase in libido and energy levels during this phase of their cycle, which aligns with the physiological surge in androgens.

Interpreting High Testosterone Results

When a blood test reveals testosterone concentrations exceeding the upper limit of the normal reference range (typically above 2.4 nmol/L), it warrants further investigation. Elevated androgens in women can manifest through various physical signs, including hirsutism (excessive facial or body hair growth), acne, and androgenic alopecia (hair thinning).

The most common endocrine disorder associated with elevated readings is polycystic ovary syndrome (PCOS)^[4]. Other potential, though less frequent, causes include congenital adrenal hyperplasia or androgen-secreting tumours. For a comprehensive overview of the symptoms, causes, and management strategies, please refer to our detailed guide on high testosterone in women.

In clinic we see many patients presenting with symptoms of hyperandrogenism, and a thorough clinical evaluation is essential to determine the underlying cause. PCOS is by far the most frequent diagnosis, affecting up to 10% of women of reproductive age. It is characterised by a combination of elevated androgens, irregular menstrual cycles, and the presence of multiple small cysts on the ovaries. Insulin resistance is also a common feature of PCOS, further complicating the hormonal profile by lowering SHBG and increasing free testosterone.

Non-classic congenital adrenal hyperplasia (NCCAH) is another potential cause of high testosterone in women. This genetic condition affects the adrenal glands’ ability to produce cortisol, leading to an overproduction of androgens as a compensatory mechanism. While less common than PCOS, NCCAH can present with similar symptoms, such as hirsutism and irregular periods, making accurate diagnosis crucial for appropriate management.

Interpreting Low Testosterone Results

Conversely, testosterone levels can fall below the expected range, particularly as women age and transition through menopause. While there is no universally agreed-upon threshold for defining clinical androgen deficiency in women, diminished levels are frequently correlated with specific symptoms.

Women with low testosterone may report a persistent lack of energy, diminished muscle strength, and a significant reduction in sexual desire (hypoactive sexual desire disorder^[5]). If you are experiencing these symptoms and your blood work indicates suboptimal androgen levels, you can explore the implications and potential therapeutic approaches in our dedicated resource on low testosterone in women.

The decline in testosterone production is a natural part of the ageing process for women, primarily driven by the gradual cessation of ovarian function during menopause. However, other factors can also contribute to low androgen levels, including surgical removal of the ovaries (oophorectomy), premature ovarian insufficiency, and certain medications, such as oral contraceptives or glucocorticoids, which can suppress ovarian or adrenal androgen production.

The clinical presentation of low testosterone in women can be subtle and often overlaps with symptoms of other conditions, such as depression, thyroid dysfunction, or the general effects of ageing. A comprehensive clinical assessment is necessary to rule out these other potential causes and determine if androgen deficiency is the primary driver of the patient’s symptoms. This evaluation typically involves a detailed medical history, physical examination, and targeted blood tests.

The Impact of Hormonal Contraceptives on Testosterone

Hormonal contraceptives, such as the combined oral contraceptive pill, the patch, and the vaginal ring, can have a profound impact on a woman’s testosterone levels. These medications typically contain synthetic oestrogen and progestin, which work together to suppress ovulation and prevent pregnancy. However, they also influence the production and bioavailability of androgens in several ways.

Firstly, the synthetic oestrogen in these contraceptives stimulates the liver to produce more sex hormone-binding globulin (SHBG). As discussed earlier, SHBG binds tightly to testosterone in the bloodstream, rendering it biologically inactive. The significant increase in SHBG caused by hormonal contraceptives leads to a corresponding decrease in free, active testosterone, even if total testosterone levels remain relatively stable.

Secondly, hormonal contraceptives suppress the release of luteinising hormone (LH) from the pituitary gland. LH is the primary signal that stimulates the ovaries to produce androgens. By inhibiting LH secretion, these medications effectively reduce the ovarian production of testosterone, further contributing to lower circulating levels.

Testosterone and Bone Health in Women

While oestrogen is widely recognised as the primary hormone responsible for maintaining bone density in women, testosterone also plays a crucial, albeit less heralded, role in skeletal health. Androgens exert both direct and indirect effects on bone metabolism, contributing to the development and maintenance of a strong and healthy skeleton throughout a woman’s life.

Directly, testosterone binds to androgen receptors located on osteoblasts, the cells responsible for bone formation. This interaction stimulates osteoblast proliferation and activity, promoting the synthesis of new bone tissue. Additionally, androgens help to inhibit the activity of osteoclasts, the cells responsible for bone resorption, thereby slowing the rate of bone loss.

Indirectly, testosterone supports bone health by serving as a precursor for oestrogen production. In peripheral tissues, such as fat and muscle, an enzyme called aromatase converts testosterone into oestradiol, a potent form of oestrogen. This local production of oestrogen is particularly important for maintaining bone density in postmenopausal women, whose ovarian oestrogen production has ceased.

The Psychological Effects of Testosterone in Women

Beyond its physical effects, testosterone also exerts a significant influence on a woman’s psychological well-being and cognitive function. The brain is a major target organ for androgens, with androgen receptors widely distributed in areas involved in mood regulation, memory, and behaviour.

Adequate levels of testosterone are associated with a positive mood, increased motivation, and a general sense of well-being. Some studies suggest that androgens may help to protect against depression and anxiety, particularly in the context of the hormonal fluctuations that occur during the menstrual cycle and the menopausal transition.

Conversely, abnormally low testosterone levels have been linked to an increased risk of mood disturbances, fatigue, and cognitive difficulties. Women with androgen deficiency often report feeling lethargic, unmotivated, and emotionally flat. These psychological symptoms can significantly impact their quality of life and interpersonal relationships.

Understanding the Complexities of Hormone Replacement Therapy

When considering the management of hormonal imbalances, particularly during the menopausal transition, Hormone Replacement Therapy (HRT) is often a central topic of discussion. While traditional HRT primarily focuses on replacing oestrogen and progesterone, the role of testosterone supplementation is increasingly being recognised and evaluated by medical professionals.

The decision to initiate any form of hormone therapy is highly individualised and must be based on a thorough assessment of a woman’s specific symptoms, medical history, and personal risk factors. For women experiencing persistent symptoms of androgen deficiency, such as profound fatigue and a distressing loss of libido that do not respond to standard HRT, the addition of testosterone may be considered.

It is crucial to understand that testosterone therapy for women is typically prescribed in much lower doses than those used for men, reflecting the naturally lower physiological requirements of the female body. The goal is to restore androgen levels to the normal physiological range for a woman’s age, rather than to achieve supraphysiological concentrations.

Understanding the Role of DHEA in Female Androgen Production

Dehydroepiandrosterone (DHEA) is a crucial precursor hormone produced primarily by the adrenal glands, with a smaller contribution from the ovaries. It serves as a vital building block for the synthesis of both androgens, including testosterone, and oestrogens in peripheral tissues. Understanding the role of DHEA is essential for a complete picture of female androgen metabolism.

DHEA levels peak during early adulthood and gradually decline with age, a process sometimes referred to as adrenopause. This age-related decrease in DHEA production contributes significantly to the overall reduction in circulating androgens experienced by women as they grow older. Because a substantial portion of a woman’s testosterone is derived from the peripheral conversion of DHEA, declining levels of this precursor can have a noticeable impact on total androgen status.

In clinical practice, measuring DHEA-S (the sulfated, more stable form of DHEA) can provide valuable insights into adrenal function and overall androgen production. Elevated DHEA-S levels may indicate adrenal hyperplasia or other adrenal abnormalities, while low levels can be associated with adrenal insufficiency or the natural ageing process. Evaluating DHEA-S alongside testosterone and SHBG offers a more comprehensive assessment of a woman’s hormonal profile.

The Influence of Thyroid Function on Testosterone Levels

The thyroid gland, located in the neck, plays a central role in regulating metabolism and energy production. However, its influence extends far beyond metabolic control, significantly impacting the function of the reproductive system and the regulation of sex hormones, including testosterone.

Thyroid disorders, such as hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid), can profoundly affect testosterone levels and bioavailability in women. Hypothyroidism is often associated with decreased production of sex hormone-binding globulin (SHBG). While this might theoretically increase free testosterone, the overall metabolic slowdown typically results in reduced total androgen production and altered hormone clearance, often leading to symptoms that mimic androgen deficiency.

Conversely, hyperthyroidism typically causes an increase in SHBG production. This elevated SHBG binds more tightly to circulating testosterone, reducing the proportion of free, biologically active hormone. Consequently, women with hyperthyroidism may experience symptoms of low testosterone, despite having normal or even elevated total testosterone levels. This highlights the critical importance of evaluating thyroid function when investigating suspected androgen imbalances.

References

1. British Menopause Society , Testosterone replacement in menopause

2. NICE , Menopause: diagnosis and management

3. Endocrine Society , Androgen Therapy in Women

4. NHS , Polycystic ovary syndrome (PCOS)

5. Mayo Clinic , Testosterone therapy for women: Is it safe?